NASDAQ
ImmunityBio, Inc. (IBRX) has a current ratio of 5.10x as of Monday, May 25, 2026. This represents a 112.63% increase compared to its 12-month average of 2.40x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.